It is mainly represented by the General Pharmaceutical Factory of Harbin Pharmaceutical Group, a key antibiotics base of China. At present, Harbin Pharmaceutical Group has an annual capacity of 8,500 tons of antibiotics and intermediate products, and 3 billion potions of injectable powder. With main products of more than 30 antibiotics including penicillins and cephalosporin, the company is second to none in production and market share of ampicillin sodium, cefotaxime sodium powder, and cefazolin sodium injectable powder. Its Penicillin G Potassium Crude has passed American FDA certificate; part of crude drugs and preparations have obtained the GMP certification issued by South African Department of Health; cefazolin sodium and ceftriaxone sodium powder has got European EDM certificate. And, its products have been exported to more than 20 countries and regions.